Atlas Trials

Imexon for Relapsed Follicular and Aggressive Lymphomas

Clinical trial NCT01314014 · COMPLETED

Trial details

NCT number
NCT01314014
Sponsor
University of Rochester
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Follicular LymphomaSmall Lymphocytic LymphomaMarginal Zone LymphomaLymphoplasmacytic LymphomaDiffuse Large B Cell LymphomaMantle Cell LymphomaBurkitt's Lymphoma
Start date
2011-05-01
Primary completion
2013-03-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.